Skip to main content
Clinical Trials/NCT03380403
NCT03380403
Completed
Not Applicable

A Clinical Trial Testing the Efficacy of PDT in Preventing Amputation in Diabetic Patients

Faculdade de Medicina do ABC0 sites34 target enrollmentJanuary 1, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetic Foot Infection
Sponsor
Faculdade de Medicina do ABC
Enrollment
34
Primary Endpoint
Infection control
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The feet of diabetic patients continue to be an important problem in medicine. In general, patients with diabetic foot have some sort of amputation, especially in underserved populations. It is clearly necessary to develop novel treatment strategies for this worldwide health problem. Photodynamic therapy (PDT) , is a low cost and highly effective alternative treatment concerning infections avoiding amputations in the diabetic foot.

Detailed Description

Patients with infected diabetic foot were grouped according to the Wagner system for classifying foot lesions. All patients presented Wagner Grade 3 classification, with osteomyelitis in one or more toes. The study included only patients who had circulatory viability. For PDT treatment the fistula and/or ulcer was used as a gateway to the bone. The treated area (bones and fingers) was irrigated with a solution of phenothiazinium salts. After that, light irradiation was performed with optical fibers or led device above the wound. PDT treatment always in outpatients, once or twice a week.

Registry
clinicaltrials.gov
Start Date
January 1, 2010
End Date
January 1, 2012
Last Updated
8 years ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

João Paulo Tardivo

Principal Investigator

Faculdade de Medicina do ABC

Eligibility Criteria

Inclusion Criteria

  • age \> 18 years old
  • diabetic foot
  • Wagner grade III

Exclusion Criteria

  • age \< 18 years old
  • non-diabetic
  • Wagner IV and V

Outcomes

Primary Outcomes

Infection control

Time Frame: every month until three months , when blood count- leucocytes reach the standard value.

blood count - leucocytes for infection

Secondary Outcomes

  • Osteomyelitis evaluation(once a month, until three months, when X-ray shows bone reconstitution .)

Similar Trials